118 related articles for article (PubMed ID: 37333140)
61. CD93 regulates central nervous system inflammation in two mouse models of autoimmune encephalomyelitis.
Griffiths MR; Botto M; Morgan BP; Neal JW; Gasque P
Immunology; 2018 Nov; 155(3):346-355. PubMed ID: 29923617
[TBL] [Abstract][Full Text] [Related]
62. CD93 has a crucial role in pathogenesis of psoriasis.
Shehata WA; Maraee AH; Tayel N; Mohamed AS; Abd El Gayed EM; Elsayed NBAE; Mostafa MI; Bazid HAS
J Cosmet Dermatol; 2022 Apr; 21(4):1616-1624. PubMed ID: 34028163
[TBL] [Abstract][Full Text] [Related]
63. Membrane Diffusion Occurs by Continuous-Time Random Walk Sustained by Vesicular Trafficking.
Goiko M; de Bruyn JR; Heit B
Biophys J; 2018 Jun; 114(12):2887-2899. PubMed ID: 29925025
[TBL] [Abstract][Full Text] [Related]
64. Identification of human CD93 as the phagocytic C1q receptor (C1qRp) by expression cloning.
Steinberger P; Szekeres A; Wille S; Stöckl J; Selenko N; Prager E; Staffler G; Madic O; Stockinger H; Knapp W
J Leukoc Biol; 2002 Jan; 71(1):133-40. PubMed ID: 11781389
[TBL] [Abstract][Full Text] [Related]
65. Crosstalk between Cancer Cells and Cancer-Associated Fibroblasts Mediated by TGF-β1-IGFBP7 Signaling Promotes the Progression of Infiltrative Gastric Cancer.
Hong Z; Xie W; Zhuo H; Wei X; Wang K; Cheng J; Lin L; Hou J; Chen X; Cai J
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568781
[TBL] [Abstract][Full Text] [Related]
66. Insulin-like growth factor binding protein 7 promotes acute kidney injury by alleviating poly ADP ribose polymerase 1 degradation.
Yu JT; Hu XW; Yang Q; Shan RR; Zhang Y; Dong ZH; Li HD; Wang JN; Li C; Xie SS; Dong YH; Ni WJ; Jiang L; Liu XQ; Wei B; Wen JG; Liu MM; Chen Q; Yang YR; Zhang GY; Zang HM; Jin J; Wu YG; Zhong X; Li J; Wang W; Meng XM
Kidney Int; 2022 Oct; 102(4):828-844. PubMed ID: 35752325
[TBL] [Abstract][Full Text] [Related]
67. The characterization of a novel monoclonal antibody against CD93 unveils a new antiangiogenic target.
Orlandini M; Galvagni F; Bardelli M; Rocchigiani M; Lentucci C; Anselmi F; Zippo A; Bini L; Oliviero S
Oncotarget; 2014 May; 5(9):2750-60. PubMed ID: 24809468
[TBL] [Abstract][Full Text] [Related]
68. The analysis of multiple omics and examination of pathological images revealed the prognostic and therapeutic significances of CD93 in lung squamous cell carcinoma.
Qu J; Lin L; Fu G; Zheng M; Geng J; Sun X; Xing L
Life Sci; 2024 Feb; 339():122422. PubMed ID: 38224815
[TBL] [Abstract][Full Text] [Related]
69. Flow cytometric identification of CD93 expression on naive T lymphocytes (CD4(+)CD45RA (+) cells) in human neonatal umbilical cord blood.
Ikewaki N; Yamao H; Kulski JK; Inoko H
J Clin Immunol; 2010 Sep; 30(5):723-33. PubMed ID: 20512406
[TBL] [Abstract][Full Text] [Related]
70. Sensitive and selective analysis of a wide concentration range of IGFBP7 using a surface plasmon resonance biosensor.
Jang DH; Choi Y; Choi YS; Kim SM; Kwak H; Shin SH; Hong S
Colloids Surf B Biointerfaces; 2014 Nov; 123():887-91. PubMed ID: 25466460
[TBL] [Abstract][Full Text] [Related]
71. Decrease in CD93 (C1qRp) expression in a human monocyte-like cell line (U937) treated with various apoptosis-inducing chemical substances.
Ikewaki N; Tamauchi H; Inoko H
Microbiol Immunol; 2007; 51(12):1189-200. PubMed ID: 18094537
[TBL] [Abstract][Full Text] [Related]
72. CD93 is Associated with Glioma-related Malignant Processes and Immunosuppressive Cell Infiltration as an Inspiring Biomarker of Survivance.
Ma K; Chen S; Chen X; Zhao X; Yang J
J Mol Neurosci; 2022 Oct; 72(10):2106-2124. PubMed ID: 36006582
[TBL] [Abstract][Full Text] [Related]
73. NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity.
Richards RM; Zhao F; Freitas KA; Parker KR; Xu P; Fan A; Sotillo E; Daugaard M; Oo HZ; Liu J; Hong WJ; Sorensen PH; Chang HY; Satpathy AT; Majzner RG; Majeti R; Mackall CL
Blood Cancer Discov; 2021 Nov; 2(6):648-665. PubMed ID: 34778803
[TBL] [Abstract][Full Text] [Related]
74. Function and expression of insulin-like growth factor-binding protein 7 (IGFBP7) gene in childhood acute myeloid leukemia.
Hu S; Chen R; Man X; Feng X; Cen J; Gu W; He H; Li J; Chai Y; Chen Z
Pediatr Hematol Oncol; 2011 May; 28(4):279-87. PubMed ID: 21413833
[TBL] [Abstract][Full Text] [Related]
75. The C-Type Lectin Receptor CD93 Regulates Platelet Activation and Surface Expression of the Protease Activated Receptor 4.
Trivigno SMG; Vismara M; Canobbio I; Rustichelli S; Galvagni F; Orlandini M; Torti M; Guidetti GF
Thromb Haemost; 2024 Feb; 124(2):122-134. PubMed ID: 37669782
[TBL] [Abstract][Full Text] [Related]
76. IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways.
Benatar T; Yang W; Amemiya Y; Evdokimova V; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2012 Jun; 133(2):563-73. PubMed ID: 21997538
[TBL] [Abstract][Full Text] [Related]
77. Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma.
Bolomsky A; Hose D; Schreder M; Seckinger A; Lipp S; Klein B; Heintel D; Ludwig H; Zojer N
J Hematol Oncol; 2015 Feb; 8():10. PubMed ID: 25887188
[TBL] [Abstract][Full Text] [Related]
78. IGFBP7-AS1 is a p53-responsive long noncoding RNA downregulated by Epstein-Barr virus that contributes to viral tumorigenesis.
Dang W; Cao P; Yan Q; Yang L; Wang Y; Yang J; Xin S; Zhang J; Li J; Long S; Zhang W; Zhang S; Lu J
Cancer Lett; 2021 Dec; 523():135-147. PubMed ID: 34634383
[TBL] [Abstract][Full Text] [Related]
79. CD93 hematopoietic stem cells improve diabetic wound healing by VEGF activation and downregulation of DAPK-1.
Zafari F; Shirian S; Sadeghi M; Teimourian S; Bakhtiyari M
J Cell Physiol; 2020 Mar; 235(3):2366-2376. PubMed ID: 31549396
[TBL] [Abstract][Full Text] [Related]
80. Insulin-like growth factor-binding protein-7 functions as a potential tumor suppressor in hepatocellular carcinoma.
Chen D; Yoo BK; Santhekadur PK; Gredler R; Bhutia SK; Das SK; Fuller C; Su ZZ; Fisher PB; Sarkar D
Clin Cancer Res; 2011 Nov; 17(21):6693-701. PubMed ID: 21908579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
